Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
1,752,839
-
Share change
-
-19,764
-
Total reported value
-
$220,201,303
-
Put/Call ratio
-
27%
-
Price per share
-
$125.63
-
Number of holders
-
80
-
Value change
-
-$1,783,807
-
Number of buys
-
29
-
Number of sells
-
35
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q2 2017
As of 30 Jun 2017,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,752,839 shares.
The largest 10 holders included
ALLIANCEBERNSTEIN L.P., MORGAN STANLEY, UBS Group AG, ROYAL BANK OF CANADA, MURPHY CAPITAL MANAGEMENT INC, Endurant Capital Management LP, Strategic Financial Services, Inc,, BOSTON RESEARCH & MANAGEMENT INC, Cambridge Investment Research Advisors, Inc., and ASPIRIANT, LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.